| Year |
Citation |
Score |
| 2023 |
Kim H, Whitman AA, Wisniewska K, Kakati RT, García-Recio S, Calhoun BC, Franco HL, Perou CM, Spanheimer PM. Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37747807 DOI: 10.1158/1078-0432.CCR-23-1248 |
0.334 |
|
| 2023 |
Kim H, Whitman AA, Wisniewska K, Kakati RT, Garcia-Recio S, Calhoun BC, Franco HL, Perou CM, Spanheimer PM. Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors. Biorxiv : the Preprint Server For Biology. PMID 37066379 DOI: 10.1101/2023.04.01.535159 |
0.402 |
|
| 2022 |
Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, De Cubas AA, Xia Y, Felsheim BM, McClure MB, Rajkovic A, Karaesmen E, Smith MA, Fan C, Ericsson PIG, et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nature Cancer. PMID 36585450 DOI: 10.1038/s43018-022-00491-x |
0.372 |
|
| 2022 |
Thennavan A, Garcia-Recio S, Liu S, He X, Perou CM. Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study. Npj Breast Cancer. 8: 83. PMID 35851387 DOI: 10.1038/s41523-022-00450-w |
0.359 |
|
| 2021 |
Regner MJ, Wisniewska K, Garcia-Recio S, Thennavan A, Mendez-Giraldez R, Malladi VS, Hawkins G, Parker JS, Perou CM, Bae-Jump VL, Franco HL. A multi-omic single-cell landscape of human gynecologic malignancies. Molecular Cell. 81: 4924-4941.e10. PMID 34739872 DOI: 10.1016/j.molcel.2021.10.013 |
0.356 |
|
| 2020 |
Garcia-Recio S, Thennavan A, East MP, Parker JS, Cejalvo JM, Garay JP, Hollern DP, He X, Mott KR, Galván P, Fan C, Selitsky SR, Coffey AR, Marron D, Brasó-Maristany F, et al. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease. The Journal of Clinical Investigation. PMID 32573490 DOI: 10.1172/Jci130323 |
0.447 |
|
| 2020 |
Marín-Aguilera M, Jiménez N, Reig Ò, Montalbo R, Verma AK, Castellano G, Mengual L, Victoria I, Pereira MV, Milà-Guasch M, García-Recio S, Benítez-Ribas D, Cabezón R, González A, Juan M, et al. Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer. Cells. 9. PMID 31947623 DOI: 10.3390/Cells9010203 |
0.508 |
|
| 2020 |
Garcia-Recio S. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease Jci. |
0.348 |
|
| 2019 |
Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, He X, Garay JP, Carey-Ewend K, Marron D, Ford J, Liu S, Vick SC, Martin M, Parker JS, et al. B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. Cell. 179: 1191-1206.e21. PMID 31730857 DOI: 10.1016/J.Cell.2019.10.028 |
0.414 |
|
| 2019 |
Allott EH, Shan Y, Chen M, Sun X, Garcia-Recio S, Kirk EL, Olshan AF, Geradts J, Earp HS, Carey LA, Perou CM, Pfeiffer RM, Anderson WF, Troester MA. Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications. Breast Cancer Research and Treatment. PMID 31535320 DOI: 10.1007/S10549-019-05442-2 |
0.337 |
|
| 2019 |
Kim SJ, Garcia-Recio S, Creighton CJ, Perou CM, Rosen JM. Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression. Oncogene. PMID 31289359 DOI: 10.1038/S41388-019-0852-0 |
0.379 |
|
| 2019 |
Marin M, Jiménez N, Reig Ò, Pereira MV, Mila M, Benitez D, Cabezón R, González A, Mengual L, Alcaraz A, Ribal MJ, García-Recio S, Juan M, Prat A, Mellado B. ARV7 and ARFL mRNA in blood to predict androgen receptor inhibitors and docetaxel response in castration-resistant prostate cancer patients. Journal of Clinical Oncology. 37: 207-207. DOI: 10.1200/Jco.2019.37.7_Suppl.207 |
0.432 |
|
| 2017 |
Marín-Aguilera M, Reig Ò, Lozano JJ, Jiménez N, García-Recio S, Erill N, Gaba L, Tagliapietra A, Ortega V, Carrera G, Colomer A, Gascón P, Mellado B. Correction: Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer. Oncotarget. 8: 27673. PMID 28460489 DOI: 10.18632/Oncotarget.17148 |
0.465 |
|
| 2017 |
Reig Ò, Marín-Aguilera M, Carrera G, Jiménez N, Paré L, García-Recio S, Gaba L, Pereira MV, Fernández P, Prat A, Mellado B. Corrigendum re: "TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer" [Eur Urol 2016;70:709-13]. European Urology. PMID 28259472 DOI: 10.1016/J.Eururo.2017.02.027 |
0.394 |
|
| 2017 |
Cejalvo JM, Martínez de Dueñas E, Galvan P, García-Recio S, Burgués Gasión O, Paré L, Antolin S, Martinello R, Blancas I, Adamo B, Guerrero-Zotano A, Muñoz M, Nuciforo P, Vidal M, Pérez RM, et al. Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer. Cancer Research. PMID 28249905 DOI: 10.1158/0008-5472.Can-16-2717 |
0.411 |
|
| 2016 |
Reig Ò, Marín-Aguilera M, Carrera G, Jiménez N, Paré L, García-Recio S, Gaba L, Pereira MV, Fernández P, Prat A, Mellado B. TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer. European Urology. PMID 26948395 DOI: 10.1016/J.Eururo.2016.02.034 |
0.412 |
|
| 2015 |
Garcia-Recio S, Gascón P. Biological and Pharmacological Aspects of the NK1-Receptor. Biomed Research International. 2015: 495704-495704. PMID 26421291 DOI: 10.1155/2015/495704 |
0.338 |
|
| 2015 |
Garcia-Recio S, Pastor-Arroyo EM, Marín-Aguilera M, Almendro V, Gascón P. The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation. Plos One. 10. PMID 26114632 DOI: 10.1371/Journal.Pone.0129661 |
0.405 |
|
| 2015 |
Marín-Aguilera M, Reig Ò, Lozano JJ, Jiménez N, García-Recio S, Erill N, Gaba L, Tagliapietra A, Ortega V, Carrera G, Colomer A, Gascón P, Mellado B. Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer. Oncotarget. 6: 10604-16. PMID 25871394 DOI: 10.18632/Oncotarget.3550 |
0.433 |
|
| 2014 |
Muñoz M, González-Ortega A, Salinas-Martín MV, Carranza A, Garcia-Recio S, Almendro V, Coveñas R. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer. International Journal of Oncology. 45: 1658-72. PMID 25175857 DOI: 10.3892/Ijo.2014.2565 |
0.411 |
|
| 2013 |
Garcia-Recio S, Fuster G, Fernandez-Nogueira P, Pastor-Arroyo EM, Park SY, Mayordomo C, Ametller E, Mancino M, Gonzalez-Farre X, Russnes HG, Engel P, Costamagna D, Fernandez PL, Gascón P, Almendro V. Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer Cancer Research. 73: 6424-6434. PMID 24030979 DOI: 10.1158/0008-5472.Can-12-4573 |
0.504 |
|
| 2012 |
Mayordomo C, García-Recio S, Ametller E, Fernández-Nogueira P, Pastor-Arroyo EM, Vinyals L, Casas I, Gascón P, Almendro V. Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2. Journal of Cellular Physiology. 227: 1358-1366. PMID 21604273 DOI: 10.1002/Jcp.22848 |
0.504 |
|
| 2011 |
Ametller E, García-Recio S, Pastor-Arroyo EM, Callejo G, Carbó N, Gascón P, Almendro V. Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death. Cancer Biology & Therapy. 11: 4-13. PMID 20980803 DOI: 10.4161/Cbt.11.1.13672 |
0.427 |
|
| 2010 |
Ametller E, García-Recio S, Costamagna D, Mayordomo C, Fernández-Nogueira P, Carbó N, Pastor-Arroyo EM, Gascón P, Almendro V. Tumor promoting effects of CD95 signaling in chemoresistant cells Molecular Cancer. 9: 161-161. PMID 20573240 DOI: 10.1186/1476-4598-9-161 |
0.403 |
|
| 2010 |
Almendro V, Garcia-Recio S, Gascon P. Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors Current Drug Targets. 11: 1169-1180. PMID 20450475 DOI: 10.2174/138945010792006807 |
0.418 |
|
| 2009 |
Almendro V, Ametller E, García-Recio S, Collazo O, Casas I, Augé JM, Maurel J, Gascón P. The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin. Plos One. 4: e4728. PMID 19266094 DOI: 10.1371/Journal.Pone.0004728 |
0.416 |
|
| Show low-probability matches. |